The study, called the Cessation or Reduction of Alcohol Consumption in Veterans trial, will enroll more than 600 veterans ages 18 to 80 at 18 VA medical centers across the country. Participants with ...

Doctors are tracking a rare rise in smell and taste disorders among GLP-1 users, raising new questions about weight-loss ...

A new clinical study has found that semaglutide—the active ingredient used in popular diabetes and weight-loss medications—could also help people with alcohol use disorder (AUD) significantly reduce ...

As Americans are encouraged to go direct with weight-loss drug prescriptions, retail pharmacy chains are poised to win big.

A South African clinical trial has found a new HIV treatment regimen causes significantly less weight gain than the standard dolutegravir treatment.

Spread the loveFor years, the quest for effective, sustainable weight loss has felt like an uphill battle for millions. Diets come and go, exercise fads burn bright and then fade, and for many, the ...

The federal government is launching a clinical trial to determine whether a popular class of weight-loss and diabetes ...

A new approach to defining obesity could help physicians better determine which patients need more intensive treatment by ...

The VA is launching a new clinical trial to test whether blockbuster GLP-1 drugs used for weight loss and type 2 diabetes can ...

Health Canada approved the weight-loss drug Zepbound for the treatment of obstructive sleep apnea in adults living with ...

For a growing number of Americans on GLP-1 weight loss medications such as Wegovy and Zepbound, staying on treatment has ...

An unlicensed semaglutide-based product that is administered under the tongue is being marketed to private doctors in the UK despite the branded medicine's manufacturer warning of safety concerns.